Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Layton

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
The Journal of Experimental Medicine|December 1, 1975
Growth of B-lymphocyte colonies in vitroD Metcalf, G J Nossal, N L Warner, et al.
The Journal of Biological Chemistry|December 15, 1991
Identification of a functional domain of human granulocyte colony-stimulating factor using neutralizing monoclonal antibodiesJ E Layton, G Morstyn, L J Fabri, et al.
Blood|December 15, 1995
Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteersA P Grigg, A W Roberts, H Raunow, et al.
The Journal of Allergy and Clinical Immunology|September 1, 1986
Immunologic response to aerosols of affinity-purified antigen in hypersensitivity pneumonitisW E Stricker, J E Layton, H A Homburger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapyG Morstyn, L Campbell, G Lieschke, et al.
Critical Care Medicine|August 2, 2000
Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortalityJ J Presneill, P M Waring, J E Layton, et al.
Lancet (London, England)|October 14, 1989
Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantationW P Sheridan, G Morstyn, M Wolf, et al.
Journal of Microscopy|February 24, 2005
A simple method allowing DIC imaging in conjunction with confocal microscopyS H Cody, S D Xiang, M J Layton, et al.
The Journal of Biological Chemistry|August 26, 1998
The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factorA Hammacher, R T Richardson, J E Layton, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
The Journal of Experimental Medicine|December 1, 1975
Growth of B-lymphocyte colonies in vitroD Metcalf, G J Nossal, N L Warner, et al.
The Journal of Biological Chemistry|December 15, 1991
Identification of a functional domain of human granulocyte colony-stimulating factor using neutralizing monoclonal antibodiesJ E Layton, G Morstyn, L J Fabri, et al.
Blood|December 15, 1995
Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteersA P Grigg, A W Roberts, H Raunow, et al.
The Journal of Allergy and Clinical Immunology|September 1, 1986
Immunologic response to aerosols of affinity-purified antigen in hypersensitivity pneumonitisW E Stricker, J E Layton, H A Homburger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapyG Morstyn, L Campbell, G Lieschke, et al.
Critical Care Medicine|August 2, 2000
Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortalityJ J Presneill, P M Waring, J E Layton, et al.
Lancet (London, England)|October 14, 1989
Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantationW P Sheridan, G Morstyn, M Wolf, et al.
Journal of Microscopy|February 24, 2005
A simple method allowing DIC imaging in conjunction with confocal microscopyS H Cody, S D Xiang, M J Layton, et al.
The Journal of Biological Chemistry|August 26, 1998
The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factorA Hammacher, R T Richardson, J E Layton, et al.
Pageof 7